Sepragen.com

Home | Contact Us 


Online Catalog


View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at sales@sepragen.com.



How Can We Help You?
Click here to contact us!

 



Sepragen signs Lab India as a distributor for its products in India

Dec 2009, Hayward, CA...Sepragen signed a distribution agreement for its products with Lab India for the Indian market. Lab India has been a distributor for many companies such as Applied Biosytems/ Life Technologies, Perkin Elmer and others in selling advanced instrumentation products to biotech, pharma markets .“ We look forward to working with Sepragen to provide high throughput technologies for bioprocessing. Cost reduction is very important for the biotech industry in the Indian market and Sepragen’s technology offers many advantages that our customers are benefitting from”, said Mr Borgaonkar of Lab India. “We have supplied products to traditional and biotech companies for research and are excited about the potential of venturing into bio-processing with Sepragen”, he added. Vinit Saxena, Sepragen’s CEO added that he was excited about the collaboration and expected to see growth in what he considered a key market.

Sepragen currently provides innovative bio-processing products that enable biotech companies to develop and produce biopharmaceuticals quickly and cost-effectively. Sepragen products are used world-wide by leading biotech companies to manufacture over twenty FDA approved drugs.

Return to News and Events main page



The statements in this release that relate to future events or performance, statements about growth, future regulatory clearances, levels of sales and market size and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of the company's products and services, the availability of components, competitors' product introductions and other risks identified in the company's SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.


Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2017 Sepragen Corporation. All rights reserved. (510) 475-0650